CPT code 84442 denotes a laboratory assay measuring thyroxine binding globulin (TBG) in patient serum. TBG measurement helps contextualize total thyroxine (T4) results by identifying variations in thyroid hormone–binding proteins that can alter total hormone concentrations without reflecting true thyroid dysfunction. Nationally, this test is used in endocrine evaluation, medication monitoring, and select diagnostic workups where altered binding capacity is suspected.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for TBG testing, typical sites of service, and what to expect from coding and billing perspectives. The report outlines common billing modifiers and payer coverage considerations where available, and highlights benchmarking and policy implications relevant to laboratory service lines.

This summary provides practical context for administrators, laboratory directors, and billing professionals seeking to align testing utilization with coding guidance and payer practices. Data not available in the input is noted where applicable in detailed sections.